You can help defeat cancer too. TROG Cancer Research relies on the generous support of our partners to continue our ground-breaking research and clinical trials.
For the estimated one in every two Australians expected to be affected by cancer, continued funding support from donors, corporate sponsors and government bodies is vital.
These partnerships help TROG Cancer Research carry out the life-saving cancer research that is key to the prevention, management, and treatment of cancer now and into the future.
TROG Cancer Research has a flexible approach to corporate partnerships and is open to any collaboration that aligns with our mission and core values and may help your organisation meet its objectives.
When you affiliate with TROG Cancer Research, you’re partnering with one of the largest clinical trials groups in Australia in its fight against cancer. With each clinical trial, our radiation medicine-focused research contributes to medical knowledge and results, facilitating important positive changes to the way people with cancer are treated.
We can partner with you in many ways to build a positive brand association and enhance social responsibility. Opportunities include cross-promotion, in-kind donations, involvement in our media campaigns, merchandising or the sponsorship of individual projects/clinical trials.
Read our Partnerships Proposal brochure to find out more.
‘The TROG Cancer Research Network and Membership is an important target audience for organisations operating in the oncology and radiation therapy sectors. The large number of radiation oncologists in Australia and New Zealand are TROG Cancer Research members, and our membership of more than 1,400 also includes people working in related oncology and clinical research disciplines.
A corporate marketing package can be tailored to suit your needs including website and member eNews advertisement; videos; social media inclusion; corporate brochures and signage as well as presentation opportunities at events.
You can also sponsor our Annual Scientific Meeting (ASM), the centrepiece of TROG Cancer Research annual calendar and a great opportunity to showcase product portfolios and develop important relationships in the radiation oncology and clinical trials sectors.
From the entire TROG Cancer Research team, we thank you and are grateful to the following organisations for their sponsorship:
To discuss corporate partnership opportunities contact Susan Goode, CEO, below.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
